Search Publications
Search

5 results for: Person: Matthew B. Weiss

Clear Results
May 3, 2021

Federal Circuit: The Doctrine of Equivalents is Not a Binary Choice

The Intellectual Property Strategist
February 18, 2021

Federal Circuit Axes Amgen Antibody Patents, Finding Lack of Enablement

February 1, 2021

2021 Biosimilar Approval and Litigation Update

November 19, 2020

For the First Time Since TC Heartland, the Federal Circuit Addresses Venue in an ANDA Case – the Holding May Also Impact BPCIA Litigation

December 20, 2018

The Patent-Eligibility Question: Aatrix, Berkheimer and Beyond